ANXIETY, DEPRESSION, QUALITY OF LIFE AND TOBACCO CONSUMPTION IN PEOPLE WITH TYPE 2 DIABETES MELLITUS
DOI:
https://doi.org/10.21134/haaj.v21i1.526Keywords:
ansiedad, calidad de vida, depresión, diabetes mellitus, tabacoAbstract
It is important to evaluate the differences in anxiety and depression, and the association between smoking and quality of life between Mexican smokers and non-smokers with Diabetes Mellitus (DM). Objective. To evaluate the differences between smokers and non-smokers with type 2 Diabetes Mellitus (T2DM) in anxiety, depression and quality of life; assess whether anxiety and depression moderate the association between quality of life and tobacco use; and evaluate the level of prediction of the quality of life towards tobacco consumption. Methodology. 44 smokers and non-smokers with T2DM. Information on the pattern of consumption, nicotine dependence, anxiety, depression, and quality of life was collected. Results. Anxiety as a trait and depression as a trait and state moderate the association between the pattern of consumption and quality of life. Conclusions. Smokers with DM had more symptoms of depression and anxiety and were more affected in quality of life. Anxiety and depression moderate the association between quality of life and nicotine dependence. The importance of taking these moderating factors into account in interventions for stop smoking and the maintenance of tobacco abstinence in people with T2DM is highlighted.
Downloads
References
Ahmed, N., Tomalika, N., Rhaman, M. M., Momtaz, H., & Haque, M. (2018). Quality of life in patients with diabetes mellitus. IMC Journal of Medical Science, 12(2), 1-8. https://doi.org/10.3329/imcjms.v12i2.39666
Akinci, F., Yildirim, A., Gözu, H., Sargini, H., Orbay, E., & Sargin, M. (2008). Assesment of health-related quality of life (HRQoL) of patients with type 2 diabetes in Turkey. Diabetes Research and Clinical Practice, 79(1), 117-123. https://doi.org/10.1016/j.diabres.2007.07.003
Alencar, D. C., Lages, P. F., Neiva, M. J. L. M., Alencar, A. M. P. G., Moreira, W. C., & Ibiapina, A. R. S. (2019). Dimensions of the quality of life negatively affected in people living with Diabetes Mellitus. Revista de Pesquisa: Cuidado é Fundamental Online, 11(1), 199-204. https://doi.org/10.9789/2175-5361.2019.v11i1.239-244
Albaroodi, K. A., Syed, S. S., Shafie, A. A., Awaisu, A., & Lajis, R. (2014). The prevalence of tobacco smoking in patients with diabetes in hospital Paulau Pinang, Malasya. Value in Health, 17, A323-A686. https://doi.org/10.1016/j.jval.2014.08.2023
American Diabetes Association. (2018). Standards of Medical Care in Diabetes-2018. Diabetes Care, 41(1), S38-S50. https://doi.org/10.2337/dc18-S004
Boyer, J., & Earp, J. (1997). The development of an instrument for assessing the quality of life of people with diabetes: Diabetes-39. Medical Care, 35(5), 440-453. https://doi.org/10.1097/00005650-199705000-00003
Centers for Disease Control and Prevention. (2017). How tobacco Smoke Causes Disease. Recuperado de https://www.cdc.gov/tobacco/data_statistics/sgr/2010/consumer_booklet/pdfs/consumer.pdf
De Miguel Díez, J., Esteban, M. M., Puente, L., Hernández, V., Carrasco, P., Alvarez-Sala, L. A., & Jiménez, R. (2010). Relationship Between Tobacco Consumption and Health-related Quality of Life in Adults Living in a Large Metropolitan Area. Lung, 188, 393-399. https://doi.org/10.1007/s00408-010-9256-1
Dirección General de Epidemiología. (2018). Distribución de casos nuevos de enfermedad por grupos de edad Estados Unidos Mexicanos 2018. Población General. Secretaría de Salud. Recuperado de http://www.epidemiologia.salud.gob.mx/anuario/2018/morbilidad/nacional/distribucion_casos_nuevos_enfermedad_grupo_edad.pdf
Domingueti, C.P., Dusse, L. M., Carvalho, M., de Sousa, L.P., Gomes, K. B., & Fernandes, A. P. (2016). Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. Journal of Diabetes and its Complications, 30, 738-745. https://doi.org/10.1016/j.jdiacomp.2015.12.018
Dzubur, A., Mehic, B., Dzubur, A., Filipovska-Musanovic, M., Denjalic, A., & Hasanbergovic, I. (2013). Quality of life for tobacco smokers in relation to their socioeconomic status. Medicinski Glasnik, 11(1), 210-215.
Etter, J. F., Le Houezec, J., & Perneger, T. V. (2003). A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. Neuropsychopharmacology, 28, 359-370. https://doi.org/10.1038/sj.npp.1300030
Fabián, M. G., & Cobo, A. C. (2007). Tabaquismo y diabetes. Revista del Instituto Nacional de Enfermedades Respiratorias, 20(2), 149-158.
Gilliani, A. H., Aziz, M. M., Bashir, S., Mustafa, A., & Fang, Y. (2017). Evaluation of Smoking Prevalence and its associated factors among the diabetics in Pakistan. Value in Health, 20(9), A853-A943. https://doi.org/10.1016/j.jval.2017.08.2863
Grandy, S., Chapman, R. H., Fox, K. M., & SHIELD Study Group. (2008). Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). International journal of clinical practice, 62(4), 562-568. https://doi.org/10.1111/j.1742-1241.2008.01703.x
Huo, L., Shaw, J. E., Wong, E., Harding, J. L., Peeters, A., & Magliano, D. J. (2016). Burden of diabetes in Australia: life expectancy and disability-free life expectancy in adults with diabetes. Diabetología, 59, 1437-1445. https://doi.org/10.1007/s00125-016-3948-x
Instituto Nacional de Salud Pública. (2016). Encuesta Nacional de Salud y Nutrición de Medio Camino 2016 Informe Final de Resultados. Recuperado de https://www.gob.mx/cms/uploads/attachment/file/209093/ENSANUT.pdf
International Diabetes Federation. (2012). Global Guideline for Type 2 Diabetes. Recuperado de https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes
International Diabetes Federation. (2017). IDF Diabetes Atlas English edition 2017. Recuperado de https://www.diabetesatlas.org/en/resources/?gclid=EAIaIQobChMInq-foKSE5wIVIf_jBx2IXwGlEAAYASAAEgJZ6_D_BwE
Kalda, R., Rätsep, A., & Lember, M. (2008). Predictors of quality of life of patients with type 2 diabetes. Patient preference and adherence, 2, 21-26.
Lira-Mandujano, J. (2009). Programa de intervención breve motivacional para fumadores y terapias de sustitución con nicotina: Resultados de un ensayo clínico aleatorio controlado. Tesis doctoral. Universidad Nacional Autónoma de México.
López-Carmona, J. M., & Rodríguez-Moctezuma, R. (2006). Adaptación y validación del instrumento de calidad de vida Diabetes 39 en pacientes mexicanos con diabetes mellitus tipo 2. Salud pública de México, 48 (3), 200-211.
López-Nicolás, A., Trapero-Bertran, M., & Muñoz, C. (2018). Smoking, health-related quality of life and economic evaluation. The European Journal of Health Economics, 19, 747-756. https://doi.org/10.1007/s10198-017-0919-1
Maric-Bilkan, C. (2017). Sex differences in micro- and macro-vascular complications of diabetes mellitus. Clinical Science, 131, 833-846. https://doi.org/10.1042/CS20160998
Martín, M., Grau, J. A., Ramírez, V., & Grau, R. (2001). El Inventario de Depresión Rasgo-Estado (IDERE): Desarrollo y Potencialidades. Revista Psicología.com, 5(1). Recuperado de http://www.psiquiatria.com/diagnostico47/el-inventario-de-depresion-rasgo-estado-idere-desarrollo-y-potencialidades
Mokhtari, Z., Gheshlagh, R. G., & Kurdi, A. (2019). Health-related quality of life in Iranian Patients with type 2 diabetes: An updated meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13, 402-407. https://doi.org/10.1016/j.dsx.2018.10.007
National Institute on Drug Abuse. (2019). Cigarettes and Other Tobacco Products. Recuperado de https://www.drugabuse.gov/publications/drugfacts/cigarettes-other-tobacco-products
Oliveira, B. C., Bomfim, E. S., Ribeiro, I. J. S., Carmo, E. A., Boery, R. N. S. O., & Boery, E. N. (2017). Factors associated with the quality of life of individuals affected by diabetes mellitus. Revista Baiana de Enfermagem, 31(4), e18247. https://doi.org/10.18471/rbe.v31i4.21481
Organización Mundial de la Salud. (2017). Diabetes. Recuperado de http://www.who.int/mediacentre/factsheets/fs312/es
Organización Mundial de la Salud. (2011). La prueba de detección de consumo de alcohol, tabaco y sustancias (ASSIST). Manual para uso en la atención primaria. Recuperado de https://www.who.int/substance_abuse/activities/assist_screening_spanish.pdf
Osme, S. F., Ferreira, L., Jorge, M. T., de Souza Andréo, J., Jorge, M., de Melo Costa Pinto, R… Jorge, P. T. (2012). Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence. Diabetology & Metabolic Syndrome, 4 (1), 39-48. https://doi.org/10.1186/1758-5996-4-39
Ou, H. T., Yang, C. Y., Wang, J. D., Hwang, J. S., & Wu, J. S. (2016). Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A National Longitudinal Cohort of Incident Cases Followed for 14 Years. Value in Health, 19, 976-984. https://doi.org/10.1016/j.jval.2016.05.017
Pizzo, M. R., Matsuo, T., Vargas, S. O. (2009). Clinical characteristics and quality of life of smokers at a referral center for smoking cessation. The Journal Brasileiro de Pneumologia, 36(1), 67-74. http://dx.doi.org/10.1590/S1806-37132010000100012
Robinson, S.M., Sobell, L. C., Sobell, M. B., & Leo, G. I. (2014). Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychology of Addictive Behaviors, 28(1), 154-162. https://doi.org/10.1037/a0030992
Roy, T., & Lloyd, E. (2012). Epidemiology of depression and diabetes: A systematic review. Journal of Affective Disorders, 142, S8-S21. https://doi.org/10.1016/S0165-0327(12)70004-6
Secretaría de Salud. (2015). Protocolo Clínico para el Diagnóstico y Tratamiento de la Diabetes. Recuperado de https://www.gob.mx/salud/documentos/protocolo-clinico-para-el-diagnostico-y-tratamiento-de-la-diabetes
Spielberger, C., & Díaz, R. (2002). Inventario de Ansiedad: Rasgo-Estado. México: Manual Moderno.
Stoddard, P., He, G., & Schillinger, D. (2010). Smoking behavior among Hispanic adults with diabetes on the United States-México border: a public health opportunity. Revista Panamericana de Salud Pública, 28 (3), 221-229.
Tovilla-Zárate, C., Juárez-Rojop, I., Peralta J. Y., Jiménez, M. A., Vázquez, S., Bermúdez-Ocaña, D., Ramón-Frías, T., Genis M. A. D., García, S. P., & López, N. L. (2012). Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican population. PLoS ONE, 7(5): e36887. https://doi.org/10.1371/journal.pone.0036887
Tweed, J. O., Hsia, S. H., Lutfy, K., & Friedman, T. C. (2012). The endocrine effects of nicotine and cigarette smoke. Trends in Endocrinology and Metabolism, 23(7), 334-342. http://dx.doi.org/10.1016/j.tem.2012.03.006
U.S. Department of Health and Human Services (2017). The Health Consequences of Smoking-50 Years of Progress. A report of the Surgeon General. Recuperado de: http://www.surgeongeneral.gov/library/reports/50-years-of-progress
Valero, K., Marante, D., Torres R., M., Ramiórez, G., Corteóz, R. y Carlini, R. (2012). Complicaciones microvasculares de la diabetes. Revista Venezolana de Endocrinologióa y Metabolismo, 10(1), 111-137.
Walker, J., Colhoun, H., Livingstone, S., McCrimmon, R., Petrie, J., Sattar, N., Wild, S., & Scottish Diabetes Research Network Epidemiology Group. (2018). Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012-2014): a population-based observational study. Diabetología, 61, 108-116. http://dx.doi.org/10.1007/s00125-017-4478-x
World Health Organization. (2018). Diabetes. Recuperado de https://www.who.int/news-room/fact-sheets/detail/diabetes
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Health and Addictions Journal/Revista Salud y Drogas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors publishing in this journal agree to the journal's statement of ethical principles and to the following terms:
The rights of the published material shall belong to their respective authors. Articles published in HAAJ may be used under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license, and may be read, copied, distributed, printed, searched, or linked to in the full text of this journal without prior permission from the publisher or author, provided that HAAJ and the authors are acknowledged and not used for commercial purposes.
Authors may include the work in institutional repositories or other publications as long as this journal is acknowledged and properly cited.
The HAAJ editorial team encourages authors to disseminate their published work through any means (conferences, classes, lectures, talks, etc.) and/or platforms (social networks, repositories, websites, etc.).
HAAJ follows the Core Practices of COPE (Committee on Publication Ethics).
How to Cite
